Unlock instant, AI-driven research and patent intelligence for your innovation.

Adeno-associated virus compositions for pah gene transfer and methods of use thereof

An adeno-associated virus and genome technology, applied in the field of adeno-associated virus composition for PAH gene transfer and its application, can solve the problems of insufficient expression duration and insufficient expression level

Pending Publication Date: 2020-11-03
HOMOLOGY MEDICINES INC
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, non-integrating vectors often suffer from insufficient levels of expression or insufficient duration of expression in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adeno-associated virus compositions for pah gene transfer and methods of use thereof
  • Adeno-associated virus compositions for pah gene transfer and methods of use thereof
  • Adeno-associated virus compositions for pah gene transfer and methods of use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0160] Example 1: Human PAH transfer vector

[0161] This example provides human PAH transfer vectors pHMI-hPAH-TC-004, pHMI-hPAH-TC-025, pHMI-hPAH-TC-010, pHMI-hPAH-TC-011 and pHMI-hPAH-TC-012, used Express human PAH in human or mouse cells.

[0162] a) pHMI-hPAH-TC-004

[0163] Such as Figure 1A As shown, the PAH transfer vector pHMI-hPAH-TC-004 contains the following genetic elements from 5' to 3': 5' ITR element, CAG promoter, silently altered human PAH coding sequence, SV40 polyadenylation sequence and 3' ITR element. The sequences of these elements are listed in Table 1. The vector is capable of expressing human PAH protein in cells transduced with the vector, such as human cells or mouse cells.

[0164] Table 1: Genetic elements in the human PAH transfer vector pHMI-hPAH-TC-004

[0165] genetic element SEQ ID NO 5'ITR element 18 CAG promoter 28 Codon-altered human PAH coding sequence 25 SV40 polyadenylation sequence 42 3'...

Embodiment 2

[0185] Example 2: Mouse PAH gene transfer in a mouse model

[0186] This example provides the mouse PAH transfer vector rAAV-CBA-mPAH, which is similar to the human PAH transfer vector pHMI-hPAH-TC-004 described in Example 1, except that the wild-type mouse PAH coding sequence is used to replace the codons Altered human PAH coding sequence. The vector is capable of expressing mouse PAH protein in cells transduced with the vector, such as human cells or mouse cells.

[0187] In short, the Pah - / - (PAH enu2 ) mice were housed in transparent polycarbonate cages with contact pads in isolators. Animals were given Picolab Mouse Diet 5058 ad libitum. Spring or tap water acidified with 1 N HCl to a target pH of 2.5-3.0 was provided ad libitum. Vectors packaged in AAVHSC15 capsids were prepared in PBS (with Ca and Mg) supplemented with 35 mM NaCl, 1% sucrose and 0.05% Pluronic F-68. The formulation was injected intravenously through the tail vein.

[0188] After administration o...

Embodiment 3

[0194] Example 3: Human PAH gene transfer in mouse model

[0195] This example demonstrates that the PAH transfer vector described in Example 1 effectively reverses the phenotype caused by PAH gene deficiency in a mouse model. The mouse model, AAV packaging and formulation, and methods for examining gene transfer efficiency were the same as described in Example 2.

[0196] To examine the efficacy of the five PAH transfer vectors in reversing the phenotype, a single dose of 2.6 × 10 13 vector genome, or 6 × 10 per kg body weight for female mice 13 dose of a vector genome. pah - / - Mice exhibit elevated levels of phenylalanine (Phe) and decreased levels of tyrosine (Tyr) in serum. like Figures 6A-6H As shown, administration of any of the five vehicles resulted in a significant decrease in Phe levels and an increase in Tyr levels within one week. This efficacy persisted for at least 12 weeks in male mice and for at least 6 weeks in female mice. With the exception of pHMI-h...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided herein are adeno-associated virus (AAV) compositions that can express a phenylalanine hydroxylase (PAH) polypeptide in a cell, thereby restoring the PAH gene function. Also provided are methods of use of the AAV compositions, and packaging systems for making the AAV compositions.

Description

[0001] related application [0002] This application claims priority to U.S. Provisional Patent Application Serial No. 62 / 625,150, filed February 1, 2018, the entire disclosure of which is incorporated herein by reference. [0003] References to Sequence Listings Submitted Electronically [0004] The contents of the electronically submitted Sequence Listing in an ASCII text file (name: HMT-025PC_SeqList_ST25.txt; size: 34214 bytes; and date created: January 27, 2019) are hereby incorporated by reference in their entirety. [0005] Background of the invention [0006] Phenylketonuria (PKU) is an autosomal recessive disorder in which most cases are caused by mutations in the phenylalanine hydroxylase (PAH) gene. The PAH gene encodes a liver enzyme that catalyzes the hydroxylation of L-phenylalanine (Phe) to L-tyrosine (Tyr) upon multimerization. Reduction or loss of PAH activity results in accumulation of phenylalanine and its conversion to phenylpyruvate (also known as benzoph...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/43A61K35/761A61K48/00C12N15/864C12N9/02C12N5/10A61P3/00
CPCA61P3/00C12N15/86C12N2750/14143C12N2750/14122A61K48/0066C12N2830/42A01K2217/075A01K2227/105A01K2267/0306C12N9/0071C12Y114/16001A61K38/00C12N2750/14152G01N33/9406A61K38/44A61K48/0058
Inventor A.B.西摩S.S.阿梅德J.B.怀特S.N.多利夫H.鲁宾
Owner HOMOLOGY MEDICINES INC